ETOPOSIDE SALVAGE THERAPY FOR REFRACTORY GERM-CELL TUMORS - AN UPDATE

被引：64

作者：

WILLIAMS, SD ^{[1
]}

EINHORN, LH ^{[1
]}

机构：

[1] VET ADM MED CTR,INDIANAPOLIS,IN 46202

来源：

CANCER TREATMENT REVIEWS | 1982年 / 9卷

关键词：

D O I：

10.1016/S0305-7372(82)80081-9

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：67 / 71

页数：5

共 9 条

[1] A PHASE-II STUDY OF ORAL VP-16-213 IN NON-SEMINOMATOUS TESTICULAR CANCER [J].

CAVALLI, F ;

KLEPP, O ;

RENARD, J ;

ROHRT, M ;

ALBERTO, P .

EUROPEAN JOURNAL OF CANCER, 1981, 17 (02) :245-249

[2]

EINHORM LH, 1979, SEMIN ONCOL, V6, P87

[3]

EINHORN L, 1981, P AM ASSOC CANC RES, V22, P463

[4]

EINHORN LH, 1978, CANCER TREAT REP, V62, P1351

[5] VP16-213 AS A SINGLE AGENT IN ADVANCED TESTICULAR-TUMORS [J].

FITZHARRIS, BM ;

KAYE, SB ;

SAVERYMUTTU, S ;

NEWLANDS, ES ;

BARRETT, A ;

PECKHAM, MJ ;

MCELWAIN, TJ .

EUROPEAN JOURNAL OF CANCER, 1980, 16 (09) :1193-1197

[6]

WILLIAMS SD, 1980, CANCER, V46, P2154, DOI 10.1002/1097-0142(19801115)46:10<2154::AID-CNCR2820461008>3.0.CO

[7]

2-3

[8]

WILLIAMS SD, 1980, P AM ASSOC CANC RES, V21, P421

[9]

WILLIAMS SM, UNPUB

← 1 →